EBI
Updated 18 days ago
Kneuterdijk 2 2514 EN Den Haag The Netherlands
EBI's lead product is based on one of the polypeptide compounds derived from the human pregnancy hormone and is currently progressing through the clinical development phases. Positive Phase II results have paved the way for a pivotal Phase III trial...
EBI's management team collaborates closely with its Scientific Advisory Board and external advisors to leverage their expertise for the full development of EBI's product pipeline. EBI actively engages in new partnerships to successfully bring this product to the market...
Learn about EBI mission and vision, the company, lead products in development, target unmet medical needs. Contact us for partnering opportunities.